NHS Whispers - NHS insights for Pharma & Medtech ’s Post

What evidence do you need to launch a new product in the NHS? In this video, Dr Faris Al-Ramadani (Former PCN Clinical Director and GP Partner in the NHS, and HealthTech and Venture Capital Consultant) describes the sort of evidence that NHS decision-makers at different levels will be looking for. Faris highlights the importance of evidence that demonstrates how your solution can be implemented within the care pathway, in addition to its impact and the value that it can add. Here are just some of the questions NHS decision-makers may have: ❓ How do we implement this product? ❓ Which populations and communities will benefit? ❓ What impact will implementation have on other areas of the system? ❓ Where else in the system has it worked? ❓ How does it help the patient? ❓ How does it improve the quality of the service that the patient receives? ❓How does it drive efficiencies and/or free up resources... and how does this help the GP practice/hospital and wider ICB? For support generating and presenting such evidence, reach out to us today at [email protected] Watch the full webinar (first recorded in July 2024) at: https://lnkd.in/e4YuUNJb #NHSWhispers #GlobalWhispers #medtech #medicaldevices #pharma #healthtech

What evidence do you need to launch a new product in the NHS? In this video, Dr Faris Al-Ramadani (Former PCN Clinical Director and GP Partner in the NHS, and HealthTech and Venture Capital Consultant) describes the sort of evidence that NHS decision-makers at different levels will be looking for. Faris highlights the importance of evidence that demonstrates how your solution can be implemented within the care pathway, in addition to its impact and the value that it can add. Here are just some of the questions NHS decision-makers may have: ❓ How do we implement this product? ❓ Which populations and communities will benefit? ❓ What impact will implementation have on other areas of the system? ❓ Where else in the system has it worked? ❓ How does it help the patient? ❓ How does it improve the quality of the service that the patient receives? ❓How does it drive efficiencies and/or free up resources... and how does this help the GP practice/hospital and wider ICB? For support generating and presenting such evidence, reach out to us today at [email protected] Watch the full webinar (first recorded in July 2024) at: https://lnkd.in/eWpKEg3M #NHSWhispers #GlobalWhispers #medtech #medicaldevices #pharma #healthtech

What evidence do you need to launch a new product in the NHS? In this video, Dr Faris Al-Ramadani (Former PCN Clinical Director and GP Partner in the NHS, and HealthTech and Venture Capital Consultant) describes the sort of evidence that NHS decision-makers at different levels will be looking for. Faris highlights the importance of evidence that demonstrates how your solution can be implemented within the care pathway, in addition to its impact and the value that it can add. Here are just some of the questions NHS decision-makers may have: ❓ How do we implement this product? ❓ Which populations and communities will benefit? ❓ What impact will implementation have on other areas of the system? ❓ Where else in the system has it worked? ❓ How does it help the patient? ❓ How does it improve the quality of the service that the patient receives? ❓How does it drive efficiencies and/or free up resources... and how does this help the GP practice/hospital and wider ICB? For support generating and presenting such evidence, reach out to us today at [email protected] Watch the full webinar (first recorded in July 2024) at: https://lnkd.in/eFAM95RG #NHSWhispers #GlobalWhispers #medtech #medicaldevices #pharma #healthtech

Loyalty Schemes in MedTech: The Need for Robust Clinical and Economic Evidence Loyalty programs in medtech face unique challenges, from strict regulations to complex stakeholder dynamics. However, the real differentiator isn’t the rewards—it’s the clinical and health economic evidence that underpins the value of medtech solutions. 1️⃣ Regulatory Compliance: Programs must align with laws, but strong clinical data ensures credibility and compliance. 2️⃣ Stakeholder Engagement: Beyond rewards, decision-makers prioritize proven outcomes and cost-effectiveness. 3️⃣ Ethics and Trust: Evidence-driven programs foster trust by focusing on patient care, not incentives. 4️⃣ Sustainable Value: High-quality evidence demonstrates the long-term value of medtech innovations, making them indispensable to healthcare providers. In medtech, loyalty is earned through outcomes, trust, and transparency, not just incentives. Robust clinical and health economic evidence is the foundation for building lasting partnerships with healthcare providers and delivering value to patients. How can evidence-based approaches shape medtech loyalty strategies? Let’s connect and share insights! #MedTech #ClinicalEvidence #HealthEconomics #PatientOutcomes #HealthcareInnovation Device Access UK Ltd IGES Lifescience IGES Institut GmbH Michael Branagan-Harris #NHS

Medication management is one of the most direct ways to improve clinical outcomes and reduce the cost of care. AI-driven solutions like MDI Health are transforming this field with hyper-personalization and enhanced drug safety at scale. Despite healthcare’s slower adoption of tech, these are the some of the top visionary pharmacy leaders I suggest following who are at the forefront of this revolution, dedicated to advancing patient care: Bahar Davidoff PharmD, MBA Justin Bioc Saba Syed, PharmD, MS, EMBA, BCACP, BCGP Laura Balsamini, PharmD, BCPS Iris Morant & Sara Gonzalez Kim Le Jodi Loyles Kevin Host, PharmD #MedicationManagement #HealthPlans #Medicare #MedicareAdvantage #HealthTech #STARs #ValueBasedCare #HealthcareInnovation #PharmacyLeaders #DigitalHealth #PopulationHealth #HealthOutcomes #AIinHealthcare

Did you know that MedTech Strategist has a sister publication focused specifically on medtech regulatory, reimbursement, and policy for your market access strategy? There's no other resource like Market Pathways in the industry. In the January 2025 Digital Edition, Market Pathways' editors Stephen Levin and David Filmore highlight the major medtech policy issues and developments they'll be tracking in 2025 and count down the top 10 global policy documents of 2024. Also, former Centers for Medicare & Medicaid Services medical director Lee Fleisher shares his views on the major reimbursement challenges currently facing product companies. And in Consultants Corner, MCRA, an IQVIA business executives offer practical guidance on diversifying device trials and implementing diversity action plans. Follow Market Pathways today. #medtech #innovation #regulatory #reimbursement

📊 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐓𝐫𝐞𝐧𝐝𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐑𝐞𝐯𝐢𝐞𝐰𝐬 📊 As we approach the end of the year, it’s clear that healthcare reviews are playing a pivotal role in shaping the industry’s future. Here’s what’s trending: ·        𝐏𝐚𝐭𝐢𝐞𝐧𝐭-𝐂𝐞𝐧𝐭𝐞𝐫𝐞𝐝 𝐂𝐚𝐫𝐞: A growing emphasis on value-based care models is driving demand for precise, evidence-based healthcare reviews to ensure patients receive the right care at the right time. ·       𝐀𝐈 & 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧: Advanced technologies are transforming utilization management and healthcare reviews, enhancing efficiency, accuracy, and decision-making processes. ·        𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐭𝐲 𝐃𝐫𝐮𝐠 𝐑𝐞𝐯𝐢𝐞𝐰𝐬: With specialty drug approvals on the rise, payers and providers rely on comprehensive reviews to manage costs while maintaining access to life-changing therapies. ·        𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: Recent CMS guidelines are further aligning healthcare reviews with transparency and quality outcomes, reinforcing accountability in the system. At Medical Review Institute of America, LLC (𝐌𝐑𝐈𝐨𝐀), we’re at the forefront of these changes, empowering better decisions through innovative solutions like 𝐇𝐢𝐠𝐡-𝐂𝐨𝐬𝐭 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐭𝐲 𝐃𝐫𝐮𝐠 𝐑𝐞𝐯𝐢𝐞𝐰𝐬™, 𝐏𝐀 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧, and more. 𝑻𝒐𝒈𝒆𝒕𝒉𝒆𝒓, 𝒘𝒆’𝒓𝒆 𝒅𝒓𝒊𝒗𝒊𝒏𝒈 𝒃𝒆𝒕𝒕𝒆𝒓 𝒐𝒖𝒕𝒄𝒐𝒎𝒆𝒔 𝒇𝒐𝒓 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔, 𝒑𝒓𝒐𝒗𝒊𝒅𝒆𝒓𝒔, 𝒂𝒏𝒅 𝒑𝒂𝒚𝒆𝒓𝒔 𝒂𝒍𝒊𝒌𝒆. 💡 What trends do you think will define healthcare in 2025? Let’s discuss! 👇 www.mrioa.com #HealthcareTrends #MedicalReviews #ValueBasedCare #AIInHealthcare #EmpoweringHealthcare #teamMRIoA

Ensuring your medical technology is reimbursed appropriately is key to its commercial success. Here’s how we can assist you: 🔑 Identify and Secure Appropriate Reimbursement Codes and Coverage: Our team will help you navigate the complex landscape of reimbursement codes and secure coverage from both insurance providers and government payers. This ensures your product is accessible to the widest possible patient base. 📊 Develop Evidence-Based Value Propositions: We work with you to create compelling, evidence-based value propositions that highlight the cost-effectiveness and clinical benefits of your product. These propositions are essential for supporting pricing and reimbursement negotiations, ensuring your product is valued accurately in the market. 🤝 Engage Early with Healthcare Providers and Payers: By engaging with healthcare providers and payers early in the product development process, we help you understand and meet their reimbursement requirements. This proactive approach ensures that your product is aligned with market needs and can be integrated seamlessly into existing reimbursement frameworks. Reach out! Our team can help you build a strong reimbursement strategy that enhances your market access and maximizes the commercial potential of your innovative medical technology. #MedTech #HealthTech #MedicalTechnology #DigitalHealth #MedDevice #HealthInnovation #WearableTech #Telemedicine #SmartHealth #BioTech #Research #MarketAccess #Reimbursement

Boost patient satisfaction and revenue growth while simplifying workflows for providers and pharmacy teams! The key? Investing in the right high-impact strategies and leveraging technologies that maximize results. Learn how Arrive Health is supporting health systems to optimize investments in this white paper. https://lnkd.in/eUW6_A3N #healthcare #priorauthorization #healthcareinnovation #pharmacy #patientcare

Mobile health is on the rise! 💡 Explore the regulatory landscape for reimbursement of Digital Therapeutics (DTx) solutions in the healthcare industry. Health authorities' approval is crucial for integrating DTx solutions into mainstream healthcare. Some solutions may even be prescribed by healthcare professionals and eligible for reimbursement in certain scenarios. Learn more about navigating the complex DTx regulatory environment in various countries with this informative whitepaper. #MobileHealth #DigitalTherapeutics #HealthcareRegulations #Reimbursement #Whitepaper Contact Us [email protected] https://lnkd.in/d2EeqHft